Human Investing’s Medifast MED Stock Holding History

Human Investing’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,020	Closed	-$209K	–	105
2023 Q1	$209K	Sell	2,020 -912	-31%	-$101K	0.05%	96
2022 Q4	$338K	Buy	+2,932	New	+$341K	0.09%	87
2022 Q3	–	Sell	-3,380	Closed	-$610K	–	117
2022 Q2	$610K	Buy	3,380 +95	+3%	+$17K	0.15%	87
2022 Q1	$561K	Buy	+3,285	New	+$619K	0.12%	96
2021 Q4	–	Sell	-3,971	Closed	-$765K	–	101
2021 Q3	$765K	Sell	3,971 -82	-2%	-$20.2K	0.18%	95
2021 Q2	$1.15M	Sell	4,053 -2,095	-34%	-$568K	0.28%	66
2021 Q1	$1.3M	Sell	6,148 -950	-13%	-$227K	0.33%	46
2020 Q4	$1.39M	Sell	7,098 -3,009	-30%	-$532K	0.39%	43
2020 Q3	$1.66M	Sell	10,107 -7,629	-43%	-$1.26M	0.55%	41
2020 Q2	$2.46M	Sell	17,736 -46	-0.3%	-$4.22K	0.87%	20
2020 Q1	$1.11M	Buy	17,782 +3,779	+27%	+$344K	0.48%	55
2019 Q4	$1.53M	Sell	14,003 -6,120	-30%	-$592K	0.5%	55
2019 Q3	$2.08M	Buy	20,123 +19,499	+3,125%	+$2.1M	0.74%	37
2019 Q2	$80K	Buy	+624	New	+$86.7K	0.03%	184

Other funds holding MED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Human Investing's MED Position: Q2 2023 in Review

Human Investing sold out of Medifast (MED) in Q2 2023, closing a stake of 2,020 shares — an estimated $209K sold.

Human Investing first reported a position in MED in Q2 2019 and held it in 14 quarters. The position peaked at $2.46M in Q2 2020. 236 funds tracked by Wall St. Rank hold MED as of Q2 2023.

Human Investing reported no remaining Medifast position as of Q2 2023 after selling out during the quarter.
Human Investing sold 2,020 Medifast shares in Q2 2023, an estimated $209K.
Human Investing first reported a position in Medifast in Q2 2019 and held it in 14 quarters.
Human Investing's Medifast position peaked at $2.46M in Q2 2020.
236 funds tracked by Wall St. Rank held Medifast as of Q2 2023.

Based on Human Investing's 13F filing for Q2 2023, filed 7 Aug 2023.